CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- 4 Grant or award Director acquired 3,081 shares (grant or award)
- 4 Grant or award Director acquired 3,081 shares (grant or award)
- 4 Grant or award Director acquired 3,081 shares (grant or award)
- 4 Open-market sale President, Pharma Services sold 200,337 shares at an average $40.35 ($8,082,901)
- 4 Open-market sale President, Clinical Services sold 130,604 shares at $39.31 ($5,134,043)
- 4 Exercise or conversion Chief Medical Officer acquired 25,050 shares (option exercise)
- 4 Grant or award Chief Executive Officer acquired 55,736 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Strategy Officer acquired 4,655 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 6,207 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 56,423 shares (grant or award)
- 4 Grant or award President, Informatics acquired 4,345 shares (grant or award)
- 4 Grant or award VP and Chief Culture Officer acquired 1,862 shares (grant or award)
- 4 Grant or award General Counsel acquired 4,345 shares (grant or award)
- 4 Grant or award President, Clinical Services acquired 6,827 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 1,241 shares (grant or award)
- 4 Grant or award President, Pharma Services acquired 6,207 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 5,276 shares (grant or award)
- 4 Exercise or conversion Director acquired 117,286 shares (option exercise)
Page 13 of 30 · 589 filings